Sort   by:  
 Page size 
Immunotherapy improves the survival of patients with advanced melanoma, 40% of whom become long-term responders. However, not all patients respond to immunotherapy. Further knowledge about the processes involved in response and resistance to immunotherapy is still needed. In this study, clinical par...
ORGANISM(S): Homo sapiens (Human) 
2023-09-25 | PXD038155 | Pride
Protein content of extracellular vesicles from serun of advanced melanoma patients treated with anti-PD1 therapy.
ORGANISM(S): Homo sapiens (Human) 
2026-02-23 | PXD062378 | Pride
Trastuzumab improves survival outcomes in patients with HER2+ metastatic breast cancer. Some of these patients may become long-term survivors. The Long-Her study was designed to identify clinical and molecular markers that could differentiate long-term survivors from patients having early progressio...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size